, Tracking Stock Market Picks
Enter Symbol:
Rating: LLY
Outperform $95

Eli Lilly And Company (NYSE: LLY) rated to Outperform with price target $95 by Leerink Partners

Monday,  Dec 28, 2015  10:25 AM ET by Kristen Bailey

Leerink Partners rated Eli Lilly And
Company (NYSE: LLY) to Outperform with price target $95 with today's price of $85.04.

Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Leerink Partners

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy